BACE1 and early-onset autosomal dominant Alzheimer disease: Future studies aimed at manipulating of polarized neuronal BACE1 trafficking to assess potential modulation of Aβ production in vivo would be necessary to evaluate if trafficking modulation of BACE1 could serve as a therapeutic strategy in Alzheimer’s disease to reduce cerebral amyloid burden.